Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 3 Jul 24 424B5 Prospectus supplement for primary offering
- 30 Jan 24 424B5 Prospectus supplement for primary offering
- 31 Jul 23 424B5 Prospectus supplement for primary offering
- 24 May 23 424B5 Prospectus supplement for primary offering
- 8 May 23 EFFECT Notice of effectiveness
-
24 Mar 23 S-3 Shelf registration
CKPT similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Checkpoint Therapeutics, Inc.
Waltham, MA
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated March 28, 2022, relating to the financial statements of Checkpoint Therapeutics, Inc., appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP
New York, New York
March 24, 2023